• March

    11

    2017
  • 296
  • 0
FDA Concern over balloon angioplasty

FDA Concern over balloon angioplasty

For those of your contemplating or have had vascular work done. Please read

FDA concern over experimental procedures that use balloon angioplasty devices to treat autonomic dysfunction: FDA safety communication

Date issued: March 8, 2017
Audiences:

Health care providers who manage the care of patients with autonomic dysfunction, including neurologists, interventionalists (radiologists, vascular surgeons, and neurosurgeons), and clinical researchers

People considering treatment options for autonomic dysfunction, including but not limited to Parkinson’s disease, multiple sclerosis (MS), fibromyalgia, multiple system atrophy, postural tachycardia syndrome (POTS), peripheral neuropathies, primary dysautonomia, familial dysautonomia.
Medical specialties: neurology, interventional radiology, vascular surgery, neurosurgery

For more information please select the link below.

US FOOD & DRUG ADMINISTRATION – SAFETY ALERTS AND NOTICES

© Copyright 2017 - All Rights Reserved by MALS Support Community
error: Content is protected !!